Built for sustainability, engineered for predictability
With every therapeutic we bring forward—whether widely used or meeting high-value niche needs—Valorum’s disciplined approach supports long-term stability, clear value, and dependable access for a diverse range of practices and patient populations.
Pipeline
preclinical
phase iphase iiiFDA/EMA Approval
AHZANTIVE©
Ophthalmology
ARMLUPEG©
Oncology
ALYMSYS©
Oncology
VA-2*
Ophthalmology
| Indications | Phase/Status | |
|---|---|---|
|
AHZANTIVE© Ophthalmology |
|
FDA/EMA Approval |
| ARMLUPEG© Oncology |
|
FDA/EMA Approval |
| ALYMSYS© Oncology |
|
FDA/EMA Approval |
|
VA-2* Ophthalmology |
|
FDA/EMA Approval |
* EMA Approved